ACE2 and COVID-19: Molecular docking techniques have been used to predict the ACE2-binding abilities of baicalin, scutellarin, hesperetin, nicotine, and glycyrrhizin, which are possible therapeutic agents for COVID-19 (Chen and Du, 2020a).